These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6812167)

  • 21. Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.
    Zoja C; Benigni A; Livio M; Bergamelli A; Orisio S; Abbate M; Bertani T; Remuzzi G
    Am J Pathol; 1989 May; 134(5):1027-38. PubMed ID: 2497648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects.
    Davì G; Custro N; Novo S; Mattina A; Strano A
    Thromb Haemost; 1983 Oct; 50(3):669-70. PubMed ID: 6417815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane generation in patients with essential hypertension or cerebrovascular disease and effect of oral aspirin.
    Matsumoto M; Nukada T; Uyama O; Yoneda S; Imaizumi M; Miyamoto T; Kayama N
    Thromb Haemost; 1980 Aug; 44(1):16-22. PubMed ID: 7423441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
    Preston FE; Greaves M; Jackson CA; Stoddard CJ
    Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
    De Caterina R; Giannessi D; Gazzetti P; Bernini W
    Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876
    [No Abstract]   [Full Text] [Related]  

  • 29. Recovery of cyclooxygenase activity after aspirin in populations of platelets separated on stractan density gradients.
    McDonald JW; Ali M
    Prostaglandins Leukot Med; 1983 Nov; 12(3):245-52. PubMed ID: 6419234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in thromboxane A2 synthesis by megakaryocytes and platelets.
    Wojenski CM; Schick PK
    J Lab Clin Med; 1991 Oct; 118(4):370-6. PubMed ID: 1940580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
    Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat.
    DeRubertis FR; Craven PA
    Metabolism; 1992 Jan; 41(1):90-6. PubMed ID: 1538647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of aspirin on megakaryocyte prostaglandin production.
    Demers LM; Budin RE; Shaikh BS
    Proc Soc Exp Biol Med; 1980 Jan; 163(1):24-9. PubMed ID: 6766214
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets.
    Fitzgerald DJ; Mayo G; Catella F; Entman SS; FitzGerald GA
    Am J Obstet Gynecol; 1987 Aug; 157(2):325-30. PubMed ID: 3618681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboxane A2 generation by the larval cestode, Taenia taeniaeformis.
    Leid RW; McConnell LA
    Clin Immunol Immunopathol; 1983 Jul; 28(1):67-76. PubMed ID: 6409486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
    J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin.
    Montalescot G; Maclouf J; Drobinski G; Salloum J; Grosgogeat Y; Thomas D
    J Am Coll Cardiol; 1994 Jul; 24(1):33-8. PubMed ID: 8006280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?
    Danesh BJ; McLaren M; Russell RI; Lowe GD; Forbes CD
    Scott Med J; 1988 Aug; 33(4):315-6. PubMed ID: 3187504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.
    Best LC; Holland TK; Jones PB; Russell RG
    Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.